Competitors of Gujarat Terce Laboratories Ltd in the Pharmaceuticals Sector
| Stock Name | Market Cap | Current Price | High / Low | Stock P/E | Book Value | Dividend Yield | ROCE | ROE | Face Value |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Themis Biosyn Ltd | 3,565 Cr. | 327 | 390/108 | 67.6 | 20.5 | 0.20 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 61.1 Cr. | 82.3 | 94.9/22.7 | 23.4 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 25.8 Cr. | 17.6 | 19.5/7.60 | 33.6 | 6.64 | 0.00 % | 4.06 % | 3.33 % | 10.0 |
| Godavari Drugs Ltd | 91.3 Cr. | 121 | 155/87.0 | 14.2 | 51.8 | 0.00 % | 12.7 % | 15.5 % | 10.0 |
| Glenmark Life Sciences Ltd | 13,431 Cr. | 1,096 | 1,335/620 | 31.7 | 207 | 2.05 % | 28.1 % | 21.1 % | 2.00 |
| Gennex Laboratories Ltd | 474 Cr. | 20.8 | 29.0/12.5 | 31.6 | 7.24 | 0.00 % | 14.4 % | 10.4 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.61 Cr. | 15.7 | 28.5/13.1 | 152 | 13.4 | 0.00 % | 3.19 % | 0.84 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 333 Cr. | 708 | 1,054/650 | 18.8 | 278 | 0.10 % | 17.6 % | 15.0 % | 10.0 |
| Fervent Synergies Ltd | 51.0 Cr. | 17.0 | 27.8/14.6 | 11.8 | 0.00 % | 34.8 % | 34.9 % | 10.0 | |
| Fermenta Biotech Ltd | 989 Cr. | 336 | 355/145 | 98.2 | 0.37 % | 3.20 % | 5.59 % | 5.00 | |
| Fabino Enterprises Ltd | 5.88 Cr. | 28.0 | 43.8/23.6 | 118 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
| Evoq Remedies Ltd | 19.9 Cr. | 8.00 | 19.4/7.30 | 44.3 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
| Everest Organics Ltd | 94.8 Cr. | 119 | 184/110 | 49.7 | 0.00 % | 6.03 % | 0.30 % | 10.0 | |
| Murae Organisor Ltd | 97.6 Cr. | 1.40 | 3.10/0.98 | 2.26 | 0.00 % | 0.79 % | 0.13 % | 2.00 | |
| Dipna Pharmachem Ltd | 17.7 Cr. | 7.36 | 14.5/6.80 | 16.2 | 15.6 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
| Decipher Labs Ltd | 16.2 Cr. | 16.1 | 25.8/14.4 | 73.9 | 21.6 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
| Coral Laboratories Ltd | 310 Cr. | 867 | 999/345 | 13.5 | 497 | 0.23 % | 12.6 % | 9.58 % | 10.0 |
| Concord Drugs Ltd | 37.5 Cr. | 37.5 | 61.5/30.6 | 33.8 | 0.00 % | 4.50 % | 1.29 % | 10.0 | |
| Colinz Laboratories Ltd | 28.9 Cr. | 63.3 | 84.4/36.0 | 52.6 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
| Cian Healthcare Ltd | 11.8 Cr. | 4.72 | 26.5/4.12 | 47.2 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 12.9 Cr. | 86.0 | 94.7/40.4 | 10.3 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
| Checkpoint Trends Ltd | 7.38 Cr. | 13.5 | 17.4/4.09 | 67.1 | 0.97 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 54.3 Cr. | 72.0 | 160/63.0 | 35.5 | 38.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
| Brawn Biotech Ltd | 7.19 Cr. | 24.0 | 27.8/14.6 | 16.9 | 0.00 % | 25.9 % | 21.8 % | 10.0 | |
| Bharat Immunological & Biological Corporation Ltd | 109 Cr. | 25.2 | 43.9/23.3 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Beryl Drugs Ltd | 20.2 Cr. | 39.8 | 46.0/19.4 | 33.6 | 17.6 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
| BDH Industries Ltd | 187 Cr. | 325 | 408/175 | 19.1 | 108 | 1.38 % | 20.6 % | 16.9 % | 10.0 |
| Bacil Pharma Ltd | 28.9 Cr. | 49.0 | 49.0/4.68 | 74.0 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
| Aurobindo Pharma Ltd | 77,786 Cr. | 1,328 | 1,593/958 | 21.7 | 509 | 0.34 % | 14.1 % | 11.5 % | 1.00 |
| Auro Laboratories Ltd | 153 Cr. | 246 | 307/112 | 19.7 | 67.3 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
| Anuh Pharma Ltd | 1,010 Cr. | 202 | 265/140 | 17.1 | 60.5 | 1.24 % | 25.6 % | 19.5 % | 5.00 |
| ANG Lifesciences India Ltd | 58.7 Cr. | 45.0 | 86.1/44.4 | 59.0 | 0.00 % | 1.78 % | 8.72 % | 10.0 | |
| Ami Organics Ltd | 8,346 Cr. | 2,039 | 2,130/1,004 | 89.4 | 294 | 0.15 % | 16.0 % | 9.37 % | 10.0 |
| Amerise Biosciences Ltd | 7.60 Cr. | 1.15 | 1.15/0.55 | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 450 Cr. | 58.7 | 77.7/35.3 | 38.2 | 17.9 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
| Adline Chem Lab Ltd | 14.9 Cr. | 25.5 | 29.0/11.9 | 2.92 | 0.00 % | % | % | 10.0 | |
| Achyut Healthcare Ltd | 112 Cr. | 66.7 | 82.5/40.2 | 170 | 18.5 | 0.00 % | 3.27 % | 2.52 % | 10.0 |
| Abbott India Ltd | 60,675 Cr. | 28,553 | 30,521/21,983 | 47.2 | 1,657 | 1.44 % | 46.0 % | 34.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 5,970 Cr. | 659 | 722/381 | 26.2 | 205 | 0.46 % | 16.6 % | 13.1 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 179 Cr. | 64.0 | 75.8/37.0 | 27.4 | 46.6 | 0.00 % | 6.18 % | 3.81 % | 10.0 |
| Zota Health Care Ltd | 1,617 Cr. | 590 | 725/400 | 34.8 | 0.17 % | 7.32 % | 16.8 % | 10.0 | |
| Wockhardt Ltd | 18,968 Cr. | 1,236 | 1,335/252 | 219 | 0.00 % | 0.83 % | 12.1 % | 5.00 | |
| Wanbury Ltd | 852 Cr. | 260 | 291/87.9 | 31.6 | 6.70 | 0.00 % | 62.5 % | % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | 21.3 | 0.00 % | 51.5 % | 163 % | 2.00 | |
| Venus Remedies Ltd | 424 Cr. | 317 | 430/280 | 19.2 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
| Unichem Laboratories Ltd | 6,334 Cr. | 900 | 938/401 | 336 | 0.00 % | 0.39 % | 1.17 % | 2.00 | |
| TTK Healthcare Ltd | 2,156 Cr. | 1,526 | 1,923/1,232 | 33.3 | 735 | 0.66 % | 8.67 % | 6.43 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,08,293 Cr. | 3,200 | 3,591/2,025 | 62.2 | 222 | 0.88 % | 23.2 % | 24.2 % | 5.00 |
| Themis Medicare Ltd | 2,546 Cr. | 277 | 304/153 | 48.0 | 44.8 | 0.18 % | 13.5 % | 11.8 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,926 Cr. | 20.5 | 27.9/9.80 | 71.3 | 3.05 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
| Suven Pharmaceuticals Ltd | 32,780 Cr. | 1,288 | 1,359/558 | 136 | 80.6 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
| Suven Life Sciences Ltd | 2,812 Cr. | 129 | 169/74.5 | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 | |
| Sun Pharmaceuticals Industries Ltd | 4,34,184 Cr. | 1,810 | 1,960/1,171 | 38.7 | 288 | 0.75 % | 17.3 % | 16.7 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 3,473 Cr. | 798 | 851/292 | 302 | 0.00 % | 8.67 % | 33.5 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 2,504 Cr. | 296 | 398/113 | 42.7 | 70.6 | 0.14 % | 11.4 % | 9.53 % | 1.00 |
| SMS Lifesciences India Ltd | 399 Cr. | 1,319 | 1,750/487 | 24.0 | 585 | 0.11 % | 6.89 % | 3.66 % | 10.0 |
| Shilpa Medicare Ltd | 8,332 Cr. | 852 | 960/313 | 203 | 208 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
| Sequent Scientific Ltd | 5,320 Cr. | 213 | 241/91.8 | 249 | 26.3 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
| Sanofi India Ltd | 14,859 Cr. | 6,452 | 7,600/4,606 | 35.2 | 298 | 2.59 % | 71.1 % | 51.5 % | 10.0 |
| RPG Life Sciences Ltd | 4,114 Cr. | 2,488 | 2,977/1,290 | 47.2 | 229 | 0.64 % | 34.6 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,222 Cr. | 5,556 | 5,836/4,637 | 40.7 | 324 | 1.04 % | 44.9 % | 33.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 267 Cr. | 75.6 | 79.2/31.9 | 20.4 | 0.00 % | 27.6 % | 16.8 % | 10.0 | |
| Pfizer Ltd | 24,391 Cr. | 5,332 | 6,453/3,855 | 39.8 | 820 | 0.65 % | 22.0 % | 16.1 % | 10.0 |
| Par Drugs & Chemicals Ltd | 368 Cr. | 299 | 325/190 | 20.2 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
| Panacea Biotec Ltd | 2,284 Cr. | 373 | 399/112 | 137 | 0.00 % | 3.57 % | 3.17 % | 1.00 | |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Orchid Pharma Ltd | 7,730 Cr. | 1,524 | 1,592/487 | 69.3 | 231 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
| Neuland Laboratories Ltd | 17,769 Cr. | 13,850 | 16,525/4,870 | 67.2 | 1,087 | 0.10 % | 33.3 % | 26.4 % | 10.0 |
| Nectar Lifescience Ltd | 837 Cr. | 37.3 | 56.5/23.6 | 136 | 47.7 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
| Natco Pharma Ltd | 25,720 Cr. | 1,436 | 1,639/729 | 15.7 | 327 | 0.66 % | 30.1 % | 25.9 % | 2.00 |
| Morepen Laboratories Ltd | 4,616 Cr. | 84.2 | 101/35.6 | 39.2 | 16.6 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
| Marksans Pharma Ltd | 13,665 Cr. | 302 | 329/114 | 41.1 | 45.6 | 0.20 % | 20.6 % | 16.5 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 175 Cr. | 110 | 145/85.2 | 55.1 | 89.9 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
| Lyka Labs Ltd | 556 Cr. | 156 | 173/97.9 | 605 | 17.9 | 0.00 % | 3.95 % | 6.61 % | 10.0 |
| Lupin Ltd | 96,326 Cr. | 2,112 | 2,312/1,154 | 42.6 | 314 | 0.38 % | 15.7 % | 14.1 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,366 Cr. | 682 | 814/498 | 14.0 | 296 | 0.26 % | 22.3 % | 16.8 % | 10.0 |
| Laurus Labs Ltd | 26,745 Cr. | 496 | 518/359 | 114 | 79.2 | 0.16 % | 7.50 % | 5.43 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 820 Cr. | 790 | 865/320 | 25.5 | 218 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 170 Cr. | 78.9 | 122/60.0 | 55.3 | 0.00 % | 19.0 % | % | 10.0 | |
| Kopran Ltd | 1,375 Cr. | 285 | 370/185 | 23.2 | 102 | 1.04 % | 13.8 % | 11.0 % | 10.0 |
| Kilitch Drugs (India) Ltd | 502 Cr. | 312 | 470/248 | 49.3 | 110 | 0.00 % | 12.8 % | 7.83 % | 10.0 |
| Jubilant Pharmova Ltd | 18,001 Cr. | 1,130 | 1,247/319 | 76.9 | 341 | 0.44 % | 6.74 % | 0.76 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 29,803 Cr. | 1,919 | 2,030/1,244 | 50.8 | 188 | 0.64 % | 24.6 % | 20.0 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,293 Cr. | 488 | 539/270 | 48.3 | 74.4 | 0.99 % | 17.0 % | 13.0 % | 5.00 |
| Ipca Laboratories Ltd | 39,641 Cr. | 1,562 | 1,709/960 | 74.8 | 250 | 0.26 % | 12.8 % | 9.35 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,302 Cr. | 392 | 538/331 | 19.4 | 274 | 1.27 % | 12.3 % | 8.68 % | 10.0 |
| Indoco Remedies Ltd | 2,902 Cr. | 315 | 417/286 | 43.3 | 120 | 0.47 % | 10.4 % | 8.33 % | 2.00 |
| Glenmark Pharmaceuticals Ltd | 47,409 Cr. | 1,680 | 1,831/702 | 278 | 0.15 % | 12.3 % | 50.9 % | 1.00 | |
| Glaxosmithkline Pharmaceuticals Ltd | 45,023 Cr. | 2,658 | 3,088/1,385 | 58.5 | 105 | 1.21 % | 51.3 % | 37.3 % | 10.0 |
| Dr Reddys Laboratories Ltd | 1,10,480 Cr. | 6,620 | 7,107/5,206 | 19.9 | 1,694 | 0.60 % | 26.5 % | 21.4 % | 5.00 |
| Dishman Carbogen Amcis Ltd | 2,744 Cr. | 175 | 283/133 | 359 | 0.00 % | 0.02 % | 2.64 % | 2.00 | |
| Cipla Ltd | 1,20,957 Cr. | 1,498 | 1,702/1,132 | 27.3 | 331 | 0.88 % | 22.8 % | 16.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 13,911 Cr. | 1,830 | 2,159/950 | 29.2 | 276 | 0.27 % | 26.5 % | 24.2 % | 2.00 |
| Brooks Laboratories Ltd | 375 Cr. | 143 | 186/72.5 | 25.0 | 0.00 % | 24.7 % | 28.1 % | 10.0 | |
| Bliss GVS Pharma Ltd | 1,313 Cr. | 125 | 150/77.4 | 12.3 | 92.4 | 0.38 % | 14.4 % | 10.2 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 108 Cr. | 66.6 | 92.0/42.6 | 172 | 11.2 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
| Biocon Ltd | 38,725 Cr. | 323 | 396/218 | 24.8 | 165 | 0.15 % | 5.96 % | 5.25 % | 5.00 |
| Beta Drugs Ltd | 1,695 Cr. | 1,763 | 2,040/892 | 46.5 | 163 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
| Bal Pharma Ltd | 189 Cr. | 118 | 158/81.2 | 25.1 | 43.4 | 1.02 % | 12.1 % | 11.1 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 200 Cr. | 84.4 | 113/73.2 | 317 | 34.2 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
| Astrazeneca Pharma India Ltd | 17,995 Cr. | 7,198 | 8,140/4,050 | 137 | 285 | 0.33 % | 31.1 % | 22.9 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,157 Cr. | 746 | 863/556 | 50.6 | 99.8 | 0.61 % | 21.3 % | 15.5 % | 1.00 |
| Alpa Laboratories Ltd | 229 Cr. | 109 | 145/69.9 | 12.1 | 77.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
| Alkem Laboratories Ltd | 71,071 Cr. | 5,944 | 6,440/3,510 | 33.2 | 862 | 0.68 % | 19.7 % | 19.6 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 21,130 Cr. | 1,075 | 1,304/707 | 33.6 | 245 | 1.01 % | 13.1 % | 13.3 % | 2.00 |
| Albert David Ltd | 801 Cr. | 1,403 | 1,754/791 | 11.3 | 671 | 0.81 % | 27.8 % | 21.7 % | 10.0 |
| Ajanta Pharma Ltd | 37,498 Cr. | 3,002 | 3,486/1,650 | 43.9 | 283 | 1.21 % | 31.6 % | 23.2 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 4,940 Cr. | 442 | 571/291 | 33.3 | 118 | 1.15 % | 15.2 % | 11.2 % | 2.00 |
| Aarti Drugs Limited | 4,468 Cr. | 486 | 635/430 | 34.6 | 128 | 0.20 % | 13.7 % | 12.4 % | 10.0 |
| Industry Average | 20,217.10 Cr | 1,275.22 | 61.75 | 190.31 | 0.31% | 16.78% | 15.93% | 6.64 |
